Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort ascending
2017 R21 RFA-CA-16-001 WONG, WESLEY PHILIP BOSTON CHILDREN'S HOSPITAL Single-molecule mechanical detection of protein and microRNA cancer biomarkers Complete
2000 R44 PAR-98-066 LIFSHITZ, NADIA BIOPHOTONICS CORPORATION HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING Complete
2002 R44 PAR-01-105 MOEN, PHILLIP T ONE CELL SYSTEMS, INC DISCRETE ASSAY FOR INTEGRATED HPV DNA IN CERVICAL CELLS Complete
2006 R33 RFA-CA-06-003 SCHNITZER, JAN EUGENIUSZ SIDNEY KIMMEL CANCER CENTER TECHNOLOGY/MAP ENDOTHELIAL TARGETS/HUMAN RENAL TUMORS Complete
2009 R21 RFA-CA-08-006 RIEHN, ROBERT NORTH CAROLINA STATE UNIVERSITY RALEIGH EPIGENETIC PROFILING BY NEAR-FIELD UV-RAMAN SCATTERING IN NANOCHANNELS Complete
2013 R21 RFA-CA-12-002 FAN, RONG YALE UNIVERSITY HIGH-THROUGHPUT, MULTIPLEXED DETECTION OF MIRNA BIOMARKERS IN SINGLE CANCER CELLS Complete
2016 R33 RFA-CA-15-003 QUEIMADO, MARIA DE LURDES UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR A NOVEL MOLECULAR ASSAY FOR EARLY DETECTION AND ASSESSMENT OF CANCER RISK Complete
2000 R21 PAR-99-102 GALE, JAMES M UNIVERSITY OF NEW MEXICO MOLECULAR STAGING OF HUMAN SQUAMOUS CELL SKIN CANCER Complete
2002 R33 PAR-99-100 GUO, BAOCHUAN CLEVELAND STATE UNIVERSITY MALDI TOF TECHNOLOGY FOR MOLECULAR ANALYSIS OF CANCER Complete
2005 R43 RFA-CA-05-006 LU, CHIUNG-MEI GENACO BIOMEDICAL PRODUCTS, INC. EXPRESSION PROFILING OF MICRORNAS WITH BEAD ARRAY Complete
2008 R42 RFA-CA-07-044 SAXENA, SATYA PRAKASH CALIBRANT BIOSYSTEMS, INC. VALIDATION AND QUANTIFICATION OF FFPE ANTIGEN RETRIEVAL BY PROTEOME ANALYSIS Complete
2011 R33 RFA-CA-10-004 BEEBE, DAVID J UNIVERSITY OF WISCONSIN-MADISON INTEGRATED MICRO SCALE TRANSCRIPTIONAL PROFILING OF CELL COMMUNICATION NETWORKS Complete
2015 R33 RFA-CA-14-004 RAPPAPORT, STEPHEN MORRIS UNIVERSITY OF CALIFORNIA BERKELEY USING ADDUCTOMICS TO CHARACTERIZE EXPOSURES TO CARCINOGENS Complete
2019 R43 PAR-18-303 BROWN, MARK T CLAREMONT BIOSOLUTIONS, LLC Rapid sample preparation method for high molecular weight DNA from tumor tissues suitable for structural variant analysis Complete
1999 R43 PAR-98-066 WINZER-SERHAN, URSULA H AMBION, INC. DEVELOPMENT OF RNA FRIENDLY, HISTOLOGICAL FIXATIVES Complete
2002 R21 PAR-01-106 DYNAN, WILLIAM S MEDICAL COLLEGE OF GEORGIA (MCG) LASER CAPTURE MICROSCOPY AND 2D-DIGE: CANCER PROTEOMICS Complete
2005 R21 RFA-CA-05-002 BROWN, KATHLYNN C UNIVERSITY OF TEXAS SW MED CTR/DALLAS A HIGH THROUGHPUT DIAGNOSTIC ASSAY FOR LUNG CANCER Complete
2008 R21 RFA-CA-07-033 MORRISON, TOM B BIOTROVE, INC. STANDARDIZED NANOARRAY PCR FOR GENE EXPRESSION PROFILING OF LUNG CANCER Complete
2011 R21 RFA-CA-10-003 FISCHBACH, CLAUDIA CORNELL UNIVERSITY MINERALIZED 3-D TUMOR MODELS TO STUDY BREAST CANCER BONE METASTASIS Complete
2015 R21 RFA-CA-14-003 PRATX, GUILLEM STANFORD UNIVERSITY HIGH-THROUGHPUT RADIONUCLIDE COUNTING AND SORTING OF SINGLE CELLS Complete
1999 R21 PAR-98-067 SHACKNEY, STANLEY E ALLEGHENY-SINGER RESEARCH INSTITUTE MOLECULAR PROFILING OF CELLS BY LASER SCANNING CYTOMETRY Complete
2001 R33 PAR-99-102 BOSS, GERRY R UNIVERSITY OF CALIFORNIA SAN DIEGO AUTOMATED MEASUREMENT OF RAS & RHO ACTIVATION IN CANCER Complete
2004 R21 PAR-01-104 ZHAO, YINGMING UNIVERSITY OF TEXAS SW MED CTR/DALLAS A NOVEL PROTEOMICS TECHNOLOGY FOR PROTEIN FARNESYLATION Complete
2007 R21 RFA-CA-07-015 SAVRAN, CAGRI PURDUE UNIVERSITY WEST LAFAYETTE LABEL-FREE DETECTION OF CANCER MARKERS USING APTAZYME-BASED AMPLIFICATION Complete
2010 R21 RFA-CA-09-006 WALDMAN, TODD A GEORGETOWN UNIVERSITY DEVELOPMENT AND APPLICATION OF ENDOGENOUS EPITOPE TAGGING TECHNOLOGY IN HUMAN CEL Complete
2014 R21 RFA-CA-13-001 KUMAR, SANJAY UNIVERSITY OF CALIFORNIA BERKELEY MOLECULAR ANALYSIS OF PHYSICAL MICROENVIRONMENTAL CONTROL OF TUMOR CELL INVASION Complete
2000 R44 PAR-98-066 ANDERSON, N LEIGH LARGE SCALE BIOLOGY CORPORATION PROTEOMIC TECHNOLOGIES FOR CANCER RESEARCH Complete
2003 R21 PAR-01-104 FERRARI, MAURO OHIO STATE UNIVERSITY NANOMECHANICAL METHOD FOR MOLECULAR ANALYSIS OF CANCER Complete
2006 R33 RFA-CA-06-003 ENGELWARD, BEVIN P. MASSACHUSETTS INSTITUTE OF TECHNOLOGY APPLICATIONS OF "RECOMBOMICE" FOR CANCER RESEARCH Complete
2009 R21 RFA-CA-08-007 YEN, YUN CITY OF HOPE/BECKMAN RESEARCH INSTITUTE ULTRAHIGH SENSITIVE, PERSONALIZED MONITORING OF LYMPHOMA RELAPSE USING BLOOD SPEC Complete
2013 R21 RFA-CA-12-002 LIOTTA, LANCE ALLEN GEORGE MASON UNIVERSITY PROTEIN PAINTING REVEALS HIDDEN PROTEIN-PROTEIN INTERACTION DOMAINS Complete
2016 R33 RFA-CA-15-003 SCARCELLI, GIULIANO UNIV OF MARYLAND, COLLEGE PARK BRILLOUIN CONFOCAL MICROSCOPY FOR BIOMECHANICAL STUDIES OF METASTATIC CASCADE IN 3D MICROENVIRONMENTS Complete
2019 R21 RFA-CA-18-002 IM, HYUNGSOON MASSACHUSETTS GENERAL HOSPITAL Nano-plasmonic technology for high-throughput single exosome analyses Active
2018 R21 RFA-CA-17-010 FU, XIAO-AN UNIVERSITY OF LOUISVILLE A microreactor chip platform for quantitative analysis of unsaturated aldehydes in exhaled breath Active
2020 R33 RFA-CA-19-020 WANG, SHAOPENG ARIZONA STATE UNIVERSITY-TEMPE CAMPUS A Virion-Display Oscillator Array and Detection Platform for Quantification of Transmembrane Protein Binding Kinetics Active
2020 R21 RFA-CA-19-019 ISSADORE, DAVID AARON UNIVERSITY OF PENNSYLVANIA High Throughput Digital Droplet ELISA for Ultrasensitive Multiplexed Diagnostics Active
2021 R21 RFA-CA-20-019 SANTORE, MARIA M UNIVERSITY OF MASSACHUSETTS AMHERST Paper-based Breastmilk Collection System for Facile, In-Home Use Active
2020 R21 RFA-CA-19-019 CICERONE, MARCUS T GEORGIA INSTITUTE OF TECHNOLOGY Label-Free Cell-Resolved Metabolomics for Tumor Microscopy Active
2019 R21 RFA-CA-18-002 WARREN, CHRISTOPHER L PROTEOVISTA, LLC SNAP-X: Development of a Mutagenesis Strategy and High Density Protein Array to Comprehensively Display Protein Variants Active
2021 R21 RFA-CA-20-017 WILSON, GERALD M UNIVERSITY OF MARYLAND BALTIMORE Suppressing oncogenic RNA regulons using engineered zinc finger ribonucleases Active
2020 R21 RFA-CA-19-019 SEELIG, GEORG UNIVERSITY OF WASHINGTON High-resolution spatial transcriptomics through light patterning Active
2019 R21 RFA-CA-18-002 KENTSIS, ALEX SLOAN-KETTERING INST CAN RESEARCH Multi-dimensional targeted mass spectrometry technology for pathway-scale functional proteomics Active
2021 R21 RFA-CA-20-017 ZHANG, FANGLIANG UNIVERSITY OF MIAMI SCHOOL OF MEDICINE Targeted degradation of proteins by affinity peptide conjugated ubiquitin (APCU) Active
2020 R21 RFA-CA-19-019 MARTO, JARROD A DANA-FARBER CANCER INST Tools for DUB Drug Discovery Active
2020 R33 RFA-CA-19-020 COOKS, ROBERT GRAHAM PURDUE UNIVERSITY Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer using Pathology Biopsies Active
2019 R21 RFA-CA-18-002 YAMAMOTO, KEITH ROBERT UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CasCUT&RUN: An in vivo method to analyze locus-specific protein complexes driving transcription of target genes in cancer Active
2021 R21 RFA-CA-20-017 STILL, AMANDA NICOLE HAYMOND GEORGE MASON UNIVERSITY New Hybrid Molecular Modalities Comprised of DNA-Origami and Interfering Peptides as Inhibitors of Protein-Protein Interactions Active
2020 R33 RFA-CA-19-020 RECHT, MICHAEL PALO ALTO RESEARCH CENTER High-Throughput Screening Platform for Cancer Drug Discovery Active
2019 R21 RFA-CA-18-002 WU, YUN STATE UNIVERSITY OF NEW YORK AT BUFFALO Exosome-Protein-microRNA-OneStop (Exo-PROS) biosensor: a new liquid biopsy for cancer screening and early detection Active
2018 R21 RFA-CA-17-010 ROYZEN, MAKSIM STATE UNIVERSITY OF NEW YORK AT ALBANY Development of Catch and Release Approach for Multi-Drug Local Delivery of Chemotherapies Active

Pages